Evidence map›Paper›PMID 42085311›Full record

ArticleAngewandte Chemie (International ed. in English)2026

Multi-Objective Catalyst Discovery in High-Entropy Alloy Composition Space: The Role of Noble Metals on the Pareto Front for Oxygen Reduction Reaction.

Mads K Plenge, Ahmad Tirmidzi, Christian M Clausen, Matthias Arenz, Jan Rossmeisl

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mads K PlengeCenter for High-Entropy Alloy Catalysis (CHEAC), Department of Chemistry, University of Copenhagen, København Ø, Denmark.
Ahmad TirmidziDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Bern, Switzerland.
Christian M ClausenCenter for High-Entropy Alloy Catalysis (CHEAC), Department of Chemistry, University of Copenhagen, København Ø, Denmark.
Matthias ArenzDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Bern, Switzerland.
Jan RossmeislCenter for High-Entropy Alloy Catalysis (CHEAC), Department of Chemistry, University of Copenhagen, København Ø, Denmark.

Funding

Danish National Research Foundation DNRF149ERC Synergy grant DEMI 101118768
6 · The paper itself

Abstract

Discovering new materials for electrocatalytic energy conversion reactions is a key step toward energy sustainability. However, for catalysts to be viable in practice, they must perform in multiple, potentially conflicting objectives. We demonstrate this challenge for the acidic oxygen reduction reaction (ORR), where activity, stability, and material cost must be balanced. Using the continuous composition space of high-entropy alloys (HEAs) together with our established models for activity and dissolution, we identify a Pareto-optimal set of ORR catalysts within the Ag─Au─Cu─Ir─Pd─Pt─Rh─Ru system via multiobjective Bayesian optimization. Additionally, we introduce a fine-tuned machine learning model that predicts adsorption energies for alloys spanning 12 elements and 9 adsorbates. Our results show that alloying expands the hypervolume spanned by the Pareto front, consisting of low- to medium-entropy alloys composed primarily of Ag, Au, Cu, Pd, and Pt. We further propose an approach for analyzing the Pareto front by quantifying the loss in hypervolume when critical elements (Au, Pd, and Pt) are removed, clarifying their relative contributions to optimal performance. This work highlights the need to consider all relevant objectives in catalyst optimization and the advantage of HEAs as a powerful platform for multiobjective catalyst discovery.

Indexed as

electrochemistryheterogeneous catalysishigh‐entropy alloysmultiobjective optimizationoxygen reduction reaction

Identifiers

PMID42085311
PMCPMC13285469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.